You trust that your hospital and physician are taking every possible step to provide the highest quality of care with the most up-to-date methods.
What steps are being taken to guarantee quality care?
Use of the Vector Surgical Tissue Orientation System, comprised of MarginMarker sterile tissue margin marking dyes and CorrectClips sterile radiographic clips, can potentially contribute to improved outcomes for you or a loved one. Improved outcomes include fewer unnecessary second operations1,2,3, more accurate re-operations1,4, lower cancer recurrence 5,6 and improved cosmesis3,4.
MarginMarker is indicated for use in cancer surgery where designation of tissue margins is important such as breast, soft tissue, prostate, ENT, pancreas, colon, liver, lip, anus, ovary, uterus and labia. CorrectClips are indicated for use in cancer surgery in which intraoperative radiograph images are utilized.
At your next appointment, consider asking your surgeon the following questions:
- How often do you take your surgical patient back to the OR for a second surgery to ensure that all the cancer is removed? How often for a third surgery?
- Do you take an x-ray of the tissue that is removed during surgery to determine if all the cancer has been removed? If you need to remove additional tissue based on this x-ray, how do you determine precisely where to take it out?
- Let’s discuss a possible situation where the pathology lab determines that there might be cancerous cells left in the body after surgery, and a second surgery is needed. In this case, what information do you use to ensure that tissue removed during the second surgery occurs in the correct location to remove all the cancerous cells?
To find a surgeon or pathologist in your area who uses MarginMarker or CorrectClips, please visit our Find a Physician page.
For additional information, we recommend the following sites:
- Meet a panel of experts who answer common patient questions.
- Singh, M.; Singh, G.; Hogan, K.T.; Atkins, K.A.; and Schroen, A.T. “The Effect of Intraoperative Specimen Inking on Lumpectomy Re-excision Rates.” World Journal of Surgical Oncology 8.4 (2010).
- Dooley, W.C. and Parker, J. “Understanding the Mechanisms Creating False Positive Lumpectomy Margins.” American Journal of Surgery 190 (2005): 606-608.
- Landercasper, J., Attai, D., Atisha, D., Beitsch, P., Bosserman, L., Boughey, J., Carter, J., Edge, S., Feldman, S., Froman, J. and Greenberg, C. “Toolbox to reduce lumpectomy reoperations and improve cosmetic outcome in breast cancer patients: The American Society of Breast Surgeons Consensus Conference.” Annals of Surgical Oncology 22.10 (2015): 3174-3183.
- Gibson, G. R.; Lesnikoski, B.A.; Yoo, J.; Mott, L.A.; Cady, B.; Barth, R.J. Jr. “A Comparison of Ink-Directed and Traditional Whole-Cavity Re-Excision for Breast Lumpectomy Specimens with Positive Margins.” Annals of Surgical Oncology 8.9 (2001): 693-704.
- Gage, I.; Schnitt, S.J.; Nixon, A.J.; Silver, B.; Recht, A.; Troyan, S.L.; Eberlein, T.; Love, S.M.; Gelman, R.; Harris, J.R.; and Connolly, J.L. “Pathologic Margin Involvement and the Risk of Recurrence in Patients Treated with Breast-Conserving Therapy.” Cancer 78.9 (1996): 1921-1928.
- Menes, T.S.; Tartter, P.I.; Bleiweiss, I.; Godbold, J.H.; Estabrook, A.; and Smith, S.R. “The Consequence of Multiple Re-excisions to Obtain Clear Lumpectomy Margins in Breast Cancer Patients.” Annals of Surgical Oncology 12.11 (2005): 881-885.
Vector Surgical, the Vector Surgical Logo, MarginMarker, and CorrectClips are trademarks of Vector Surgical, LLC. Reg. U.S. Pat & TM Off.